MS
64
3
PYPL
49
4
URBN
67
3
SYK
50
4
PSX
24
2
KMI
69
8
VRSN
59
4
ZBH
69
15
BLK
47
3
AEE
51
3
HAL
40
11
EW
55
5
FITB
36
3
AMP
43
2
MAC
53
5
AAP
26
5
JNJ
30
4
NWS
69
5
T
32
2
NOV
45
2
MS
64
3
PYPL
49
4
URBN
67
3
SYK
50
4
PSX
24
2
KMI
69
8
VRSN
59
4
ZBH
69
15
BLK
47
3
AEE
51
3
HAL
40
11
EW
55
5
FITB
36
3
AMP
43
2
MAC
53
5
AAP
26
5
JNJ
30
4
NWS
69
5
T
32
2
NOV
45
2
Financhill
Back

United Therapeutics 10K Form

Sell
49

UTHR
United Therapeutics

Last Price:
$362.61
Seasonality Move:
6.42%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-01 10Q UTHR/United Therapeutics Quarterly
2023-11-01 10Q UTHR/United Therapeutics Quarterly
2023-08-02 10Q UTHR/United Therapeutics Quarterly
2023-05-03 10Q UTHR/United Therapeutics Quarterly
2022-11-02 10Q UTHR/United Therapeutics Quarterly
2022-08-03 10Q UTHR/United Therapeutics Quarterly

Receive UTHR News And Ratings

See the #1 stock for the next 7 days that we like better than UTHR

UTHR Financial Statistics

Sales & Book Value

Annual Sales: $2.3B
Cash Flow: $300.7M
Price / Cash Flow: 19.58
Annual Sales: $136.74
Price / Book: 2.63

Profitability

EPS (TTM): 22.77000
Net Income (TTM): $1.1B
Gross Margin: $2.1B
Return on Equity: 19.26%
Return on Assets: 16.09%

United Therapeutics Earnings Forecast

Key United Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 25 years for UTHR is 88.94%.
  • The Selling, General & Administrative Expenses for UTHR have been equal to 20.50% of Gross Profit Margin.
  • The Research & Development expenses have been 17.53% of Revenue.
  • The Interest Expense is 6.02% of Operating Income.
  • The Net Earning history of UTHR is 42.31% of Total Revenues.
  • Per Share Earnings over the last 26 years have been positive in 17 years.

United Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: UTHR
CUSIP: 91307C
Website: unither.com

Debt

Debt-to-Equity Ratio: 0.07
Current Ratio: 4.58
Quick Ratio: 4.2

Price-to-Earnings

Trailing P/E Ratio: 18.15
Forward P/E Ratio: 12.15

UTHR Technical Analysis vs Fundamental Analysis

Sell
49
United Therapeutics (UTHR) is a Sell

Is United Therapeutics a Buy or a Sell?